Yili Chuanning Biotechnology Co.,Ltd. (SHE:301301)
China · Delayed Price · Currency is CNY 8.90
0.00 (0.00%)
At close: May 29, 2026
SHE:301301 Market Cap
SHE:301301 has a market cap or net worth of 19.85 billion as of May 29, 2026. Its market cap has decreased by -23.83% in one year.
Market Cap
19.85B
Enterprise Value
20.43B
Revenue
4.41B
Ranking
n/a
PE Ratio
34.02
Stock Price
8.90
Market Cap Chart
Since December 27, 2022, SHE:301301's market cap has decreased from 22.34B to 19.85B, a decrease of -11.15%. That is a compound annual growth rate of -3.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 19.85B | -12.23% |
| Dec 31, 2025 | 22.61B | -14.39% |
| Dec 31, 2024 | 26.41B | 41.47% |
| Dec 29, 2023 | 18.67B | -6.15% |
| Dec 30, 2022 | 19.89B | -10.95% |
| Dec 27, 2022 | 22.34B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Suzhou Zelgen Biopharmaceuticals | 26.68B |
| Beijing Tiantan Biological Products | 25.98B |
| Hualan Biological Engineering | 24.67B |
| BrightGene Bio-Medical Technology | 23.82B |
| Xiamen Amoytop Biotech | 22.65B |
| Sinocelltech Group | 18.49B |
| Chengdu Olymvax Biopharmaceuticals | 15.47B |
| Anhui Anke Biotechnology (Group) | 13.79B |